MIRA Pharmaceuticals, Inc. Common Stock (MIRA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $26.52M
Last updated: Nov 17, 2026 at 4:18 PM ET
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Statistics
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a market cap of $26.52M and an enterprise value of $24.01M. Its share count is up 118.01% from a year earlier.
Total Valuation
Enterprise value is 9.45% below the market cap, as cash exceeds debt.
| Market Cap | $26.52M |
|---|---|
| Enterprise Value | $24.01M |
| Latest price (Nov 17, 2026) | $0.64 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Aug 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 53.62% over 52 weeks and trades 7.25% below its 50-day average.
| Beta (1Y) | 1.04 |
|---|---|
| 52-Week Change | -53.62% |
| 1-Month Change | -0.33% |
| 3-Month Change | -16.89% |
| 6-Month Change | -32.63% |
| Total Return (1Y) | -53.62% |
| Total Return (3Y CAGR) | -42.23% |
| Max Drawdown (1Y) | -68.23% |
| Max Drawdown (3Y) | -89.66% |
| Sharpe Ratio (1Y) | -1.09 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $0.69 |
| 200-Day Average | $0.92 |
| 52-Week Range | $0.51 to $1.69 |
| RSI (14 Days) | 51.5 |
| Average Volume (20 Days) | 157.32K |
Financial Position
Current assets cover 16.97x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 16.97x |
|---|---|
| Quick Ratio | 16.97x |
| Debt / Equity | 0.00x |
| Interest Coverage | 61.00x |
Returns and Efficiency
Return on equity is -142.73% and return on assets is -134.36% over the last 12 months.
| Return on Equity (ROE) | -142.73% |
|---|---|
| Return on Assets (ROA) | -134.36% |
| Return on Capital Employed (ROCE) | -141.43% |
Scores
MIRA has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$9.50M |
| Pretax Income | -$9.76M |
| Net Income | -$9.76M |
| EBIT | -$9.68M |
| Reported EPS (TTM) | -$0.27 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 94.09% of the $7.27M in total assets.
| Cash and Equivalents | $2.50M |
|---|---|
| Total Debt | $0 |
| Net Cash | $2.50M |
| Net Cash Per Share | $0.06 |
| Working Capital | $6.81M |
| Shareholder Equity | $6.84M |
| Book Value Per Share | $0.16 |
| Total Assets | $7.27M |
| Total Liabilities | $426.18K |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$4.84M |
|---|---|
| FCF Per Share | -$0.12 |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +21.73% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +21.73% |
Dividends and Yields
MIRA does not pay a dividend.
| Buyback Yield | -14.26% |
|---|---|
| Shareholder Yield | -14.26% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MIRA
What is MIRA's market cap?
MIRA Pharmaceuticals, Inc. Common Stock has a market cap of $26.52M. Its enterprise value, which adds debt and subtracts cash, is $24.01M.
How many shares of MIRA are outstanding?
MIRA Pharmaceuticals, Inc. Common Stock has 42.02M shares outstanding. The count is up 118.01% from a year earlier.
Does MIRA pay a dividend?
No. MIRA Pharmaceuticals, Inc. Common Stock does not pay a dividend.
How much debt does MIRA have?
MIRA Pharmaceuticals, Inc. Common Stock has $0 of total debt and $2.50M of cash and equivalents, a net cash position of $2.50M.
MIRA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors